v3.26.1
Related Party Transactions - Revenue Recognition (Details) - Janssen Pharmaceuticals Inc - Asset Purchase Agreement - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Related Party Transaction [Line Items]    
Deferred revenue at period-end $ 66,896 $ 62,403
Other amounts collected or invoiced 1,881  
Deferred revenue recognized as service revenue during the period (2,635)  
Effects of exchange rate changes $ 5,247